Asymchem's World-Class TIDES Hub: Scaling Innovations For The Future
This video offers a forward‑looking view of how an integrated TIDES ecosystem can accelerate the path from molecular design to commercial drug launch. It highlights a fully connected infrastructure that links in‑house amino acid production, peptide and oligonucleotide manufacturing, and mature drug‑product capabilities into a single, scalable platform. Viewers are introduced to a world‑class TIDES hub designed to streamline upstream and downstream operations—including PFS and cartridge filling—while enabling global programs to progress with greater reliability and speed.
Emerging technologies such as MCSGP purification, PAT‑enabled process control, enzyme‑catalyzed ligation, and TAPS‑based synthesis are shown advancing toward full commercialization, supporting increasingly complex pipelines. The video also previews a major expansion: a new 130,000‑square‑meter campus designed to house dedicated capacity for TIDES and high‑potency APIs. This investment reflects a proactive approach to meeting future demand and strengthening supply‑chain resilience.
For teams navigating growing modality complexity, the video demonstrates how a unified technological framework can reduce friction, enhance manufacturability, and support confident progression from innovation to market.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.